Our study aimed to assess the potential additive effect of the PNPLA3 I148M and TM6SF2 E167K variants on the risk of NAFLD in Qingdao Han Population, China. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.